2m 2m 2m 2m 2m 2m 2m
Harrow (HROW)
NASDAQ
$41.25+$0.30 (+0.74%)
Price as of Aug 21, 2026 7:55 PM EDT- $1.5BMarket Cap
- 4.68%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Harrow (HROW)
$41.25+$0.30 (+0.74%)
HROW | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $40.95 | ||
Change | -$1.11 (-2.64%) | ||
Open | $42.50 | ||
High | $42.70 | ||
Low | $40.81 | ||
Previous Close | $42.06 | ||
Volume | 466,462 | ||
30-Day Average Volume | 553,452 | ||
1-Week Change | 2.30% | ||
1-Month Change | -6.31% | ||
1-Year Change | 4.68% | ||
3-Year Change | 144.77% | ||
5-Year Change | 347.05% | ||
Fundamentals | |||
Shares Outstanding | 37.5M | ||
Total Assets | $416.8M | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $70.6M | ||
Net Income | -$17.3M | ||
Free Cash Flow | -$10.2M | ||
EBIT | -$17.3M | ||
EBITDA | -$16.8M | ||
Net Working Capital | $127.1M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -104 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 101 | ||
P/E | -89 | ||
PEG | -2 | ||
Price/Free Cash Flow | -150 | ||
Price/Operating Cash Flow | -157 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 02/08/2013 | ||
Earnings & Revenue